African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5229

Full Length Research Paper

Molecular analysis and in vitro susceptibility profiling of some clinically important Candida spp. to the common antifungal drugs

Ahmed Medhat Mohsen Hanafy1 and Mohamed Rashed Abdu El Hamid Morsy2*
1Department of Microbiology, Faculty of Science, Ain Shams University, El-Khalifa El-Maanon street, Abbasiya square, Cairo 11566, Egypt. 2Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Yosief Abbas Street, 6th District, Madinat Nasr, Cairo 11787, Egypt.
Email: [email protected]

  •  Accepted: 10 September 2012
  •  Published: 06 November 2012


This study aimed to determine the in vitro susceptibility profiles of a group of Candidaspecies to some of the common antifungal drugs in clinical use. Thirty nine Candidaisolates were collected from the blood of immunocompromised patients with cancer. Isolates were cultivated on CHROMagar, identified using API20C kit and the ID was confirmed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Candida albicans was found to be the most frequently isolated yeast (46%) in comparison to the other species Candida krusei (28%), Candida tropicalis(13%), Candida glabrata (10.4%) and Candida parapsilosis (2.6%). PCR based analysis of the transposable intron in the 25S rDNA of C. albicans isolates revealed that 72, 17 and 11% of the isolates belonged to genotype A, B and C, respectively. Susceptibility testing of the Candida isolates against five antifungal drugs (amphotericin B, 5-flucytosine, miconazole, itraconazole and fluconazole) was carried out using the broth microdilution  method, and The MICs values for all five antifungal drugs was determined. The susceptibility profiles indicated that all isolates were susceptible to amphotericin B; most of the isolates were susceptible to 5-flucytosine and miconazole, while the susceptibility of the Candida isolates towards fluconazole and itraconazole varied depending on the species.


Key words: Clinical candidaisis, immunocompromised patients, susceptibility tests, polymerase chain reaction-restriction fragment length polymorphism assay, genotyping.